Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian M Isaacs

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Nature Metabolism|September 22, 2025
The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseasesFemke M Feringa, Sascha J Koppes-den Hertog, Lian Y Wang, et al.
EMBO Molecular Medicine|November 9, 2017
G-quadruplex-binding small molecules ameliorate <i>C9orf72</i> FTD/ALS pathology <i>in vitro</i> and <i>in vivo</i>Roberto Simone, Rubika Balendra, Thomas G Moens, et al.
Nature Neuroscience|February 29, 2024
PolyGR and polyPR knock-in mice reveal a conserved neuroprotective extracellular matrix signature in C9orf72 ALS/FTD neuronsCarmelo Milioto, Mireia Carcolé, Ashling Giblin, et al.
The EMBO Journal|May 17, 2018
Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosisPietro Fratta, Prasanth Sivakumar, Jack Humphrey, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 5, 2022
Development of a sensitive trial-ready poly(GP) CSF biomarker assay for <i>C9orf72</i>-associated frontotemporal dementia and amyotrophic lateral sclerosisKatherine M Wilson, Eszter Katona, Idoia Glaria, et al.
Acta Neuropathologica|May 22, 2010
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degenerationHazel Urwin, Keith A Josephs, Jonathan D Rohrer, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Nature Metabolism|September 22, 2025
The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseasesFemke M Feringa, Sascha J Koppes-den Hertog, Lian Y Wang, et al.
EMBO Molecular Medicine|November 9, 2017
G-quadruplex-binding small molecules ameliorate <i>C9orf72</i> FTD/ALS pathology <i>in vitro</i> and <i>in vivo</i>Roberto Simone, Rubika Balendra, Thomas G Moens, et al.
Nature Neuroscience|February 29, 2024
PolyGR and polyPR knock-in mice reveal a conserved neuroprotective extracellular matrix signature in C9orf72 ALS/FTD neuronsCarmelo Milioto, Mireia Carcolé, Ashling Giblin, et al.
The EMBO Journal|May 17, 2018
Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosisPietro Fratta, Prasanth Sivakumar, Jack Humphrey, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 5, 2022
Development of a sensitive trial-ready poly(GP) CSF biomarker assay for <i>C9orf72</i>-associated frontotemporal dementia and amyotrophic lateral sclerosisKatherine M Wilson, Eszter Katona, Idoia Glaria, et al.
Acta Neuropathologica|May 22, 2010
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degenerationHazel Urwin, Keith A Josephs, Jonathan D Rohrer, et al.
Pageof 10